Silicon Republic July 28, 2021
Biologit founder Nicole Baker believes automation will become increasingly important for screening scientific literature.
Immunologist Nicole Baker has more than two decades of experience in academia, pharma regulation and clinical research.
While working in the biotech and pharma industry, Baker specifically worked in the area of pharmacovigilance, which involves reviewing the vast number of medical extracts published each year as well as, increasingly, forums such as social media, to identify any red flags regarding adverse effects of drugs on the market.
Using this extensive knowledge, she went on to create Biologit, an artificial intelligence start-up that aims to help keep patients safe by simplifying the detection of adverse events from drug development to post-market. It does this by automating the...
Today's Sponsors
Today's Sponsor